Corebridge Financial’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-57,515
Closed -$127K 1253
2025
Q1
$127K Sell
57,515
-852
-1% -$1.87K ﹤0.01% 2319
2024
Q4
$89.3K Sell
58,367
-4,406
-7% -$6.74K ﹤0.01% 2600
2024
Q3
$125K Sell
62,773
-386
-0.6% -$768 ﹤0.01% 2486
2024
Q2
$221K Buy
+63,159
New +$221K ﹤0.01% 2133